Beutler J A, Clark P, Alvarado A B, Golik J
PRI/DynCorp., NCI-Frederick Cancer Research & Development Center, MD 21702-1201.
J Nat Prod. 1994 May;57(5):629-33. doi: 10.1021/np50107a010.
A minor congener of esperamicin A1 [1], designated esperamicin P (BMY-41339, 2), was isolated from a fermentation broth of Actinomadura verrucosospora and determined to differ from esperamicin A1 by having a methyl tetrasulfide moiety instead of a methyl trisulfide. It was active against xenografted tumors in mice and exhibited antimicrobial activity. Interconversions of 2 and 1 have been observed for DMSO solutions of both congeners at room temperature.
从疣孢马杜拉放线菌的发酵液中分离出一种埃斯佩拉霉素A1 [1]的次要同系物,命名为埃斯佩拉霉素P(BMY - 41339,2),经测定其与埃斯佩拉霉素A1的不同之处在于具有一个甲基四硫化物部分而非甲基三硫化物。它对小鼠体内的异种移植肿瘤具有活性,并表现出抗菌活性。在室温下,已观察到两种同系物的二甲基亚砜溶液中2和1之间的相互转化。